Abstract
INTRODUCTION
The aging of the population in the United States will result in a two-fold
increase in the 65 and over population by 2030, a population that accounts for
the highest incidence and prevalence of eye conditions and diseases. This sets
the stage for increased research and development activities, speedy market
approvals, and higher awareness through education. Additionally, current
market competitors will endure pressure from the industry to continually
provide advances in therapies and equipment and to compete with emerging
competitors, who focus significantly on unmet needs of the ophthalmic
consumer, including treatments for back of the eye conditions. The industry is
likely to experience a burst of new products and heavy competition as the U.S.
ophthalmic market advances.
SCOPE OF STUDY
This report contains:
- A thorough evaluation of the U.S. prescription ophthalmic pharmaceutical,
device, diagnostic, and surgical market, with forecasts to 2011
- Market analysis focused on specific diseases and conditions such as
cataract, glaucoma and refractive treatments
- Information regarding incidence and prevalence of eye conditions and risk
factors associated with those conditions
- Examination of research and development activities with an emphasis on
segments offering benefits to aging populations
- Profiles of the major companies in the industry as well as a detailed
patent analysis.
METHODOLOGY
The information for this BCC report was obtained through primary and secondary
data collection methods. Primary methods included interviews with key
executives, product managers, and clinical specialists involved in the
ophthalmic drug industry. Secondary methods included published literature in
the area of ophthalmic drugs, investment reports, company literature, and
various medical and business journals.
All market data pertains the U.S. market at the manufacturers' level. Data is
expressed in current U.S. dollars. The base year of the report is 2006, with
historical data provided for 2004 and 2005 and forecast data provided for
2011. Historical, base year, and forecast data is provided for each market
segment of the report. Competitor market shares are provided for each market
segment for the 2006 base year.
| 
View Cart
